A Solid Tumor Study for Long Term Treatment of Cancer Patients Who Participated in Adagrasib Studies
Clinical trial NCT07415031 · RECRUITING
Trial details
- NCT number
- NCT07415031
- Sponsor
- Mirati Therapeutics Inc.
- Status
- RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2026-05-06
- Primary completion
- 2028-02-16
- Enrollment
- 170
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.